Patent & IP news for September 25, 2016

ChIPs Global Summit Report 3: Congratulations - your patent has been allowed, when is it finally final? from ipkitten.blogspot.com

Problems, problems everywhere,but
where is the solution for the dual-track system?The problem of a dual track system was the final session the AmeriKat attended before lunch on the first day of the ChIPs ...

Share via E–mail | Twitter | Facebook

A song of Ice and Ice from ipkitten.blogspot.com



Iceland, a country famous for the northern lights, skyr yoghurt, and their recent performance in the Euros, has made headlines this week for threatening the trade mark rights of a major UK supermarket. The cause ...

Share via E–mail | Twitter | Facebook

Eye ‘should’ve’ done that! – Specsavers nears approval to trade mark single word “should’ve” & “shouldve” from ipkitten.blogspot.com

As briefly reported by this blog, a few weeks ago Specsavers filed an application with the UK Intellectual Property Office to have SHOULD'VE and SHOULDVE registered as trade marks in Classes 9, 10, 16 ...

Share via E–mail | Twitter | Facebook

ChIPs Global Summit Report 4: Facebook, Apple and the DoJ discuss the tension between privacy and security from ipkitten.blogspot.com


The privacy v security panel ready for a robust
debateOn the evening of the first day of the ChIPs Global Summit, the AmeriKat surrounded herself with some more inspiring women, in the form of ...

Share via E–mail | Twitter | Facebook

September 25, 2016: Last Sunday Morning with Charles Osgood. Jane Pauley named replacement. from ipbiz.blogspot.com


The beginning of the special episode Celebrating Charlie included a sun with a bowtie. A different edition of Sunday morning. Last day of hosting. Black suit, white shirt. First up, Rita Braver tells Charlie: Relax ...

Share via E–mail | Twitter | Facebook

Traditional equitable defenses do not apply to IPR proceedings from patentlyo.com

Husky Injection Molding v. Athena Automation (Fed. Cir. 2016) Referring to the headline. The PTAB (acting on behalf of the PTO Director) held that traditional equitable defenses do not apply to IPR proceedings.  Because this ...

Share via E–mail | Twitter | Facebook

Conference & CLE Calendar from www.patentdocs.org

September 29, 2016 - IP & Diagnostics Symposium (Biotechnology Innovation Organization) - Alexandria, VA September 29, 2016 - "Patent Inventorship: Best Practices for Determination and Correction -- Distinguishing Between Inventor and Contributor; Navigating Joint Inventorship, Disclosure of Ownership, and Real ...

Share via E–mail | Twitter | Facebook

FDA Approves Amjevita -- Amgen's HUMIRA® Biosimilar from www.patentdocs.org

By Andrew Williams -- On Friday, the FDA approved Amgen's application to market Amjevita (adalimumab-atto), a biosimilar to AbbVie's HUMIRA (adalimumab) fully human anti-TNF-α antibody. This marks the fourth biosimilar approved by the FDA ...

Share via E–mail | Twitter | Facebook